Skip to content
Screener

Mirum Pharmaceuticals, Inc. MIRM Common Stock Shares Issued

Common Stock Shares Issued at other companies

Gilead Sciences logo
Gilead SciencesGILD
1.2B-0.1%
Rhythm Pharmaceuticals, Inc. logo
Rhythm Pharmaceuticals, Inc.RYTM
68.4M
ALN
Alnylam PharmaceuticalsALNY
133.7M+2.1%
BridgeBio Pharma logo
BridgeBio PharmaBBIO
205.9M
Zevra Therapeutics, Inc. logo
Zevra Therapeutics, Inc.ZVRA
60.9M+7.5%
Rigel Pharmaceuticals logo
Rigel PharmaceuticalsRIGL
18.3M+3.4%

Other financials

Income statement

See full
Revenue$176.2M+37.9%
Operating income-$42.5M-753%
Net income-$67.2M-1,047%
EPS (diluted)-$1.06-783%

Balance sheet

See full
Cash & equivalents$262.7M+39.4%
Total debt$12.9M+29.2%
Total equity-$10.4M-104%
Total assets$1.0B+44.0%

Cash flow

See full
Operating cash flow-$44.3M-468%
CapEx$23.0K-81.7%
Free cash flow-$44.3M-472%

Valuation

See full
Market cap$6.02B+81.9%
Enterprise value$5.77B+84.3%
P/S9.7×+2.0×

Profitability

See full
Operating margin-134.9%-151pp
Net margin-139.2%-156pp
FCF margin-37%

Returns & leverage

See full
Return on equity-335.8%-377pp
Debt / equity0.1×0.0×
Current ratio2.9×-0.3×

Where this comes from

Reported directly by Mirum Pharmaceuticals, Inc. in its filing.

Tagged under the XBRL concept us-gaap:CommonStockSharesIssued.

The source filing: Mirum Pharmaceuticals, Inc.’s 10-Q, filed August 5, 2026.

Filed
Aug 5, 2026, 4:06 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001759425-26-000045
Line itemJune 30,2026December 31,2025
Commitments and contingencies
Stockholders’ (deficit) equity:
Preferred stock, $0.0001 par value; 10,000,000 shares authorized, and no shares issued and outstanding as of June 30, 2026 and December 31, 2025
Common stock, $0.0001 par value; 200,000,000 shares authorized; 64,754,699 and 51,896,391 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively65
Additional paid-in capital1,515,172981,878
Accumulated deficit(1,524,926)(667,544)
Accumulated other comprehensive (loss) income(674)351
Total stockholders’ (deficit) equity(10,422)314,690

Item 1. Financial Statements (Unaudited)

FAQ

What is Mirum Pharmaceuticals, Inc.'s common stock shares issued?
Mirum Pharmaceuticals, Inc. (MIRM) reported common stock shares issued of 64.8M in Q2 2026.
How has Mirum Pharmaceuticals, Inc.'s common stock shares issued changed year-over-year?
Mirum Pharmaceuticals, Inc.'s common stock shares issued increased by 29.4% year-over-year, from 50.1M to 64.8M.
What is the long-term trend for Mirum Pharmaceuticals, Inc.'s common stock shares issued?
Over 2 years (2023 to 2025), Mirum Pharmaceuticals, Inc.'s common stock shares issued has grown at a 5.4% compound annual growth rate (CAGR), from 46.7M to 51.9M.
What does common stock shares issued mean?
The total number of shares that have been authorized and distributed by the corporation since its inception. This includes shares held by the public (outstanding) as well as any shares that the company has repurchased and holds in its treasury. It represents the historical volume of equity capital creation.

Ask your AI about Mirum Pharmaceuticals, Inc.'s common stock shares issued.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude